UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.940-947

2016

Volltextzugriff (PDF)

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study

Journal of thrombosis and haemostasis, 2008-04, Vol.6 (4), p.569-576

2008

Volltextzugriff (PDF)

Anti‐FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII‐Specific Recall Response in vitro

Scandinavian journal of immunology, 2017-08, Vol.86 (2), p.91-99

2017

Volltextzugriff (PDF)

Management of acquired haemophilia A

Hamostaseologie, 2015, Vol.35 (4), p.311

2015

Volltextzugriff (PDF)

siRNA Mediated Knockdown of Tissue Factor Expression in Pigs for Xenotransplantation

American journal of transplantation, 2015-05, Vol.15 (5), p.1407-1414

2015

Volltextzugriff (PDF)

Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-03, Vol.19 (2), p.236-241

2013

Volltextzugriff (PDF)

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32)

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.154-161

2008

Volltextzugriff (PDF)

Treatment of lupus-prone NZB/NZW F 1 mice with recombinant soluble Fcγ receptor II (CD32)

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.154-161

2008

Volltextzugriff (PDF)

Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (4), p.736-742

2008

Volltextzugriff (PDF)

Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia

Journal of thrombosis and haemostasis, 2004-01, Vol.2 (1), p.193-194

2004

Volltextzugriff (PDF)

PB0142 FVIII-Containing Immune Complexes Interrupt Platelet Aggregation in an Ex-Vivo Model of Primary Hemostasis

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101090, Article 101090

2023

Volltextzugriff (PDF)

CD8α⁺βlow Effector T Cells in Systemic Lupus Erythematosus

Scandinavian journal of immunology, 2008-05, Vol.67 (5), p.501-508

2008

Volltextzugriff (PDF)

CD8β/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

Clinical and experimental immunology, 2003-09, Vol.133 (3), p.334-343

2003

Volltextzugriff (PDF)

Anti-Fc[gamma]RIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response inￂ vitro

Scandinavian journal of immunology, 2017-08, Vol.86 (2), p.91

2017

Volltextzugriff (PDF)

LB 01.2 Emicizumab Prophylaxis Instead of Immunosuppressive Therapy in Patients with Acquired Hemophilia A (AHA)

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100289, Article 100289

2023

Volltextzugriff (PDF)

CMV Complications in Common Variable Immunodeficiency

Immunobiology (1979), 2000-08, Vol.202 (2), p.194-198

2000

Volltextzugriff (PDF)

CD8 + T Cell Populations in Common Variable Immunodeficiency

Immunobiology (1979), 2000-08, Vol.202 (2), p.168-171

2000

Volltextzugriff (PDF)

Treatment of lupus-prone NZB/NZW F sub(1) mice with recombinant soluble Fc gamma receptor II (CD32)

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.154-161

2008

Volltextzugriff (PDF)

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc[GAMMA] receptor II (CD32)

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.154

2008

Volltextzugriff (PDF)

CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

Clinical and experimental immunology, 2003-09, Vol.133 (3), p.334-343

2003

Volltextzugriff (PDF)

CD8(beta)/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

Clinical and experimental immunology, 2003-09, Vol.133 (3), p.334

2003

Volltextzugriff (PDF)

CD8alpha+beta(low) effector T cells in systemic lupus erythematosus

Scandinavian journal of immunology, 2008-05, Vol.67 (5), p.501-508

2008

Volltextzugriff (PDF)

CD8 super(+) T Cell Populations in Common Variable Immunodeficiency

Immunobiology (1979), 2000-08, Vol.202 (2), p.168-171

2000

Volltextzugriff (PDF)

Inhibition of lupus disease by anti–double‐stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F 1 mouse

Arthritis and rheumatism, 2005-11, Vol.52 (11), p.3629-3638

2005

Volltextzugriff (PDF)

Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia

Journal of thrombosis and haemostasis : JTH, 2004, Vol.2 (1), p.193-194

2004

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(54)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study

Anti‐FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII‐Specific Recall Response in vitro

Management of acquired haemophilia A

siRNA Mediated Knockdown of Tissue Factor Expression in Pigs for Xenotransplantation

Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32)

Treatment of lupus-prone NZB/NZW F 1 mice with recombinant soluble Fcγ receptor II (CD32)

Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia

Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia

PB0142 FVIII-Containing Immune Complexes Interrupt Platelet Aggregation in an Ex-Vivo Model of Primary Hemostasis

CD8α⁺βlow Effector T Cells in Systemic Lupus Erythematosus

CD8β/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

Anti-Fc[gamma]RIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response inￂ vitro

LB 01.2 Emicizumab Prophylaxis Instead of Immunosuppressive Therapy in Patients with Acquired Hemophilia A (AHA)

CMV Complications in Common Variable Immunodeficiency

CD8 + T Cell Populations in Common Variable Immunodeficiency

Treatment of lupus-prone NZB/NZW F sub(1) mice with recombinant soluble Fc gamma receptor II (CD32)

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc[GAMMA] receptor II (CD32)

CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

CD8(beta)/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

CD8alpha+beta(low) effector T cells in systemic lupus erythematosus

CD8 super(+) T Cell Populations in Common Variable Immunodeficiency

Inhibition of lupus disease by anti–double‐stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F 1 mouse

Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia

Suchergebnisse filtern